Shaomin Yan1, Guang Wu. 1. Guangxi Academy of Sciences, 98 Daling Road, Nanning, Guangxi Province, 530007, China.
Abstract
OBJECTIVE: The ornithine transcarbamylase is a mitochondrial matrix homotrimeric enzyme, whose deficiency is the most common genetic defect of the urea cycle and an X-linked semidominant disorder. To understand its mutation pattern is very helpful for managing its clinical manifest and outcome. METHODS: The amino-acid pair predictability is used to transfer the symbolized human ornithine transcarbamylase and its 117 missense point mutants to scalar data and classify the amino-acid pairs as predictable and unpredictable in order that we can analyse the mutation pattern in scalar data domain rather than symbol domain. RESULTS: The results show that the mutation is highly likely to occur at the unpredictable amino-acid pairs, and the mutation has the trend to make an amino-acid pair approach predictable. CONCLUSION: The results provide insight on mutation from the viewpoint based on random mechanism.
OBJECTIVE: The ornithine transcarbamylase is a mitochondrial matrix homotrimeric enzyme, whose deficiency is the most common genetic defect of the urea cycle and an X-linked semidominant disorder. To understand its mutation pattern is very helpful for managing its clinical manifest and outcome. METHODS: The amino-acid pair predictability is used to transfer the symbolized humanornithine transcarbamylase and its 117 missense point mutants to scalar data and classify the amino-acid pairs as predictable and unpredictable in order that we can analyse the mutation pattern in scalar data domain rather than symbol domain. RESULTS: The results show that the mutation is highly likely to occur at the unpredictable amino-acid pairs, and the mutation has the trend to make an amino-acid pair approach predictable. CONCLUSION: The results provide insight on mutation from the viewpoint based on random mechanism.
Authors: Marshall L Summar; Frederick Barr; Sheila Dawling; Wendy Smith; Brendan Lee; Rani H Singh; William J Rhead; Lisa Sniderman King; Brian W Christman Journal: Crit Care Clin Date: 2005-10 Impact factor: 3.598
Authors: Mendel Tuchman; Brendan Lee; Uta Lichter-Konecki; Marshall L Summar; Marc Yudkoff; Stephen D Cederbaum; Douglas S Kerr; George A Diaz; Margaretta R Seashore; Hye-Seung Lee; Robert J McCarter; Jeffrey P Krischer; Mark L Batshaw Journal: Mol Genet Metab Date: 2008-06-17 Impact factor: 4.797
Authors: Katharina Engel; Jean-Marc Nuoffer; Chris Mühlhausen; Vera Klaus; Carlo R Largiadèr; Konstantinos Tsiakas; René Santer; Bendicht Wermuth; Johannes Häberle Journal: Mol Genet Metab Date: 2008-04-25 Impact factor: 4.797